Edition:
United Kingdom

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

2.54USD
8:35pm GMT
Change (% chg)

$-0.08 (-3.05%)
Prev Close
$2.62
Open
$2.50
Day's High
$2.58
Day's Low
$2.46
Volume
45,676
Avg. Vol
135,218
52-wk High
$5.10
52-wk Low
$2.20

Chart for

About

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $123.90
Shares Outstanding(Mil.): 47.29
Dividend: --
Yield (%): --

Financials

  ADMP.OQ Industry Sector
P/E (TTM): -- 28.00 29.57
EPS (TTM): -0.69 -- --
ROI: -69.14 13.26 12.77
ROE: -76.71 15.04 14.47

BRIEF-Adamis Pharmaceuticals Says Working With Sandoz To Prepare Symjepi Launch

* ADAMIS PHARMACEUTICALS - WORKING CLOSELY WITH SANDOZ TO PREPARE A SUCCESSFUL LAUNCH FOR SYMJEPI

27 Aug 2018

Earnings vs. Estimates